Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Practicing Proper Sanitization and Disinfection of Medical Equipment

On this episode of Champions of Care, a Champion Chair podcast, host Daniel Litwin and Champion Manufacturing Product Support Manager Melissa Hirth sat down for a discussion on the importance of proper sanitization and disinfection of medical equipment in the wake of the spread of COVID-19. These practices extend to chairs and medical…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Practicing Proper Sanitization and Disinfection of Medical Equipment

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

On this episode of Champions of Care, a Champion Chair podcast, host Daniel Litwin and Champion Manufacturing Product Support Manager Melissa Hirth sat down for a discussion on the importance of proper sanitization and disinfection of medical equipment in the wake of the spread of COVID-19.

These practices extend to chairs and medical recliners like the ones Champion provides, and keeping up with best practices to ensure they’re cleaned thoroughly and regularly can aid the world’s front-line response to the pandemic.

It’s also critical, Hirth said, to choose equipment designed with infection prevention in mind.

“Nurses and doctors are not used to this level of disinfection on products that really should be thrown away after each use,” she said. “Because COVID-19 is such a rapidly evolving situation with constant development of new or even conflicting information – I can tell you that a lot of the studies confirm that the detection of the virus on surfaces (lasts) for hours or sometimes even days, depending on the surface.

“So proper disinfection and choosing medical equipment that has those infection-prevention measures is more important than ever.”

Also important, Hirth said, is the difference between cleaning and disinfecting, as both are critically important. Hirth labeled cleaning as “the actual removal of dirt and grime from a surface,” adding that it helps remove allergens, microorganisms, and more. Though it helps remove germs, it doesn’t actually kill them.

Disinfection, then, refers to “killing a high percentage of germs on a surface, which renders them incapable of reproducing.” Sanitization simply lowers the number of germs on a surface, and sterilization is the most extreme form of removal, removing essentially all types of life on a surface.

Cleaning should happen before disinfection, Hirth said, to remove barriers in front of a disinfectant’s ability to get to the germs it’s targeting.

Champion also engineers its chairs for aiding in infection control, listening to clients to develop strategies that help them more efficiently and thoroughly clean their products.

To that end, Champion chairs feature:

  • Swing-Away Arms
  • Quick-Release Seat (Removable with No Tools)
  • Access to Every Surface of the Chair
  • Replacement Covers
  • Gasketed Heat and Massage Components

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512